A detailed history of Brown Brothers Harriman & CO transactions in Novartis Ag stock. As of the latest transaction made, Brown Brothers Harriman & CO holds 52,932 shares of NVS stock, worth $5.52 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
52,932
Previous 55,920 5.34%
Holding current value
$5.52 Million
Previous $5.95 Million 2.27%
% of portfolio
0.04%
Previous 0.05%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$106.13 - $120.89 $317,116 - $361,219
-2,988 Reduced 5.34%
52,932 $6.09 Million
Q2 2024

Aug 09, 2024

BUY
$92.57 - $107.37 $724,175 - $839,955
7,823 Added 16.27%
55,920 $5.95 Million
Q1 2024

May 10, 2024

SELL
$95.27 - $108.47 $14,290 - $16,270
-150 Reduced 0.31%
48,097 $4.65 Million
Q4 2023

Feb 12, 2024

SELL
$92.27 - $101.54 $1.2 Million - $1.32 Million
-13,045 Reduced 21.28%
48,247 $4.87 Million
Q3 2023

Nov 13, 2023

SELL
$94.73 - $105.13 $127,506 - $141,504
-1,346 Reduced 2.15%
61,292 $6.24 Million
Q2 2023

Aug 07, 2023

SELL
$92.52 - $104.91 $101,772 - $115,401
-1,100 Reduced 1.73%
62,638 $6.32 Million
Q1 2023

May 11, 2023

SELL
$80.03 - $92.81 $582,378 - $675,378
-7,277 Reduced 10.25%
63,738 $5.86 Million
Q4 2022

Feb 09, 2023

SELL
$75.55 - $92.52 $194,767 - $238,516
-2,578 Reduced 3.5%
71,015 $6.44 Million
Q3 2022

Nov 10, 2022

SELL
$74.61 - $87.26 $753,710 - $881,500
-10,102 Reduced 12.07%
73,593 $5.59 Million
Q2 2022

Aug 11, 2022

SELL
$80.52 - $93.75 $1.05 Million - $1.23 Million
-13,094 Reduced 13.53%
83,695 $7.08 Million
Q1 2022

May 13, 2022

SELL
$80.11 - $90.62 $2.18 Million - $2.46 Million
-27,201 Reduced 21.94%
96,789 $8.49 Million
Q4 2021

Feb 14, 2022

SELL
$79.7 - $88.13 $1.44 Million - $1.59 Million
-18,014 Reduced 12.69%
123,990 $10.8 Million
Q3 2021

Nov 15, 2021

SELL
$81.78 - $95.14 $862,288 - $1 Million
-10,544 Reduced 6.91%
142,004 $11.6 Million
Q2 2021

Aug 13, 2021

SELL
$85.24 - $94.15 $3.87 Million - $4.27 Million
-45,346 Reduced 22.91%
152,548 $13.9 Million
Q1 2021

May 13, 2021

SELL
$83.5 - $98.47 $6.87 Million - $8.1 Million
-82,295 Reduced 29.37%
197,894 $16.9 Million
Q4 2020

Feb 16, 2021

SELL
$78.07 - $94.43 $4.78 Million - $5.78 Million
-61,208 Reduced 17.93%
280,189 $26.5 Million
Q3 2020

Nov 16, 2020

SELL
$82.14 - $91.0 $297 Million - $329 Million
-3,613,526 Reduced 91.37%
341,397 $29.7 Million
Q2 2020

Aug 13, 2020

SELL
$80.93 - $91.1 $11.1 Million - $12.5 Million
-137,049 Reduced 3.35%
3,954,923 $345 Million
Q1 2020

May 15, 2020

SELL
$70.67 - $99.01 $20.9 Million - $29.2 Million
-295,413 Reduced 6.73%
4,091,972 $337 Million
Q4 2019

Feb 14, 2020

SELL
$84.35 - $95.37 $29.9 Million - $33.8 Million
-354,912 Reduced 7.48%
4,387,385 $415 Million
Q3 2019

Nov 14, 2019

SELL
$85.54 - $94.26 $103 Million - $114 Million
-1,206,226 Reduced 20.28%
4,742,297 $412 Million
Q2 2019

Aug 14, 2019

SELL
$75.4 - $92.8 $14.9 Million - $18.3 Million
-197,729 Reduced 3.22%
5,948,523 $543 Million
Q1 2019

May 15, 2019

SELL
$75.32 - $86.15 $25.3 Million - $28.9 Million
-335,406 Reduced 5.17%
6,146,252 $591 Million
Q4 2018

Feb 14, 2019

SELL
$73.66 - $82.02 $76.2 Million - $84.9 Million
-1,034,853 Reduced 13.77%
6,481,658 $556 Million
Q3 2018

Nov 14, 2018

SELL
$66.94 - $77.43 $35.9 Million - $41.6 Million
-536,968 Reduced 6.67%
7,516,511 $648 Million
Q2 2018

Aug 14, 2018

SELL
$64.91 - $73.36 $56.5 Million - $63.9 Million
-871,065 Reduced 9.76%
8,053,479 $608 Million
Q1 2018

May 14, 2018

SELL
$70.39 - $84.15 $18.8 Million - $22.5 Million
-267,086 Reduced 2.91%
8,924,544 $722 Million
Q4 2017

Feb 14, 2018

SELL
$72.33 - $77.64 $63.6 Million - $68.3 Million
-879,198 Reduced 8.73%
9,191,630 $772 Million
Q3 2017

Nov 14, 2017

SELL
$74.14 - $77.27 $5.91 Million - $6.16 Million
-79,721 Reduced 0.79%
10,070,828 $865 Million
Q2 2017

Aug 14, 2017

BUY
N/A
10,150,549
10,150,549 $847 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Brown Brothers Harriman & CO Portfolio

Follow Brown Brothers Harriman & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brown Brothers Harriman & CO, based on Form 13F filings with the SEC.

News

Stay updated on Brown Brothers Harriman & CO with notifications on news.